1 Study Coverage 1.1 Antibody Drugs Product Introduction 1.2 Market by Type 1.2.1 Global Antibody Drugs Market Size Growth Rate by Type 1.2.2 Monoclonal Antibodies 1.2.3 Antibody-Drug Conjugates 1.2.4 Polyclonal Antibodies 1.3 Market by Application 1.3.1 Global Antibody Drugs Market Size Growth Rate by Application 1.3.2 Central Nervous System (CNS) Disorders 1.3.3 Cancers 1.3.4 Autoimmune Disorders 1.3.5 Cardiovascular Diseases 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Antibody Drugs Market Size, Estimates and Forecasts 2.1.1 Global Antibody Drugs Revenue 2016-2027 2.1.2 Global Antibody Drugs Sales 2016-2027 2.2 Global Antibody Drugs, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Antibody Drugs Historical Market Size by Region (2016-2021) 2.3.1 Global Antibody Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Antibody Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Antibody Drugs Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Antibody Drugs Sales Forecast by Region (2022-2027) 2.4.2 Global Antibody Drugs Revenue Forecast by Region (2022-2027) 3 Global Antibody Drugs Competitor Landscape by Players 3.1 Global Top Antibody Drugs Manufacturers by Sales 3.1.1 Global Antibody Drugs Sales by Manufacturer (2016-2021) 3.1.2 Global Antibody Drugs Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Antibody Drugs Manufacturers by Revenue 3.2.1 Key Antibody Drugs Manufacturers Covered: Ranking by Revenue 3.2.2 Global Antibody Drugs Revenue by Manufacturers (2016-2021) 3.2.3 Global Antibody Drugs Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Antibody Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Antibody Drugs Revenue in 2020 3.2.6 Global Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Antibody Drugs Price by Manufacturers 3.4 Global Antibody Drugs Manufacturing Base Distribution, Product Types 3.4.1 Antibody Drugs Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Antibody Drugs Product Type 3.4.3 Date of International Manufacturers Enter into Antibody Drugs Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Antibody Drugs Market Size by Type (2016-2021) 4.1.1 Global Antibody Drugs Sales by Type (2016-2021) 4.1.2 Global Antibody Drugs Revenue by Type (2016-2021) 4.1.3 Antibody Drugs Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Antibody Drugs Market Size Forecast by Type (2022-2027) 4.2.1 Global Antibody Drugs Sales Forecast by Type (2022-2027) 4.2.2 Global Antibody Drugs Revenue Forecast by Type (2022-2027) 4.2.3 Antibody Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Antibody Drugs Market Size by Application (2016-2021) 5.1.1 Global Antibody Drugs Sales by Application (2016-2021) 5.1.2 Global Antibody Drugs Revenue by Application (2016-2021) 5.1.3 Antibody Drugs Price by Application (2016-2021) 5.2 Antibody Drugs Market Size Forecast by Application (2022-2027) 5.2.1 Global Antibody Drugs Sales Forecast by Application (2022-2027) 5.2.2 Global Antibody Drugs Revenue Forecast by Application (2022-2027) 5.2.3 Global Antibody Drugs Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Antibody Drugs Market Size YoY Growth 2016-2027 6.1.1 China Antibody Drugs Sales YoY Growth 2016-2027 6.1.2 China Antibody Drugs Revenue YoY Growth 2016-2027 6.1.3 China Antibody Drugs Market Share in Global Market 2016-2027 6.2 China Antibody Drugs Market Size by Players (International and Local Players) 6.2.1 China Top Antibody Drugs Players by Sales (2016-2021) 6.2.2 China Top Antibody Drugs Players by Revenue (2016-2021) 6.3 China Antibody Drugs Historic Market Review by Type (2016-2021) 6.3.1 China Antibody Drugs Sales Market Share by Type (2016-2021) 6.3.2 China Antibody Drugs Revenue Market Share by Type (2016-2021) 6.3.3 China Antibody Drugs Price by Type (2016-2021) 6.4 China Antibody Drugs Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Antibody Drugs Sales Forecast by Type (2022-2027) 6.4.2 China Antibody Drugs Revenue Forecast by Type (2022-2027) 6.4.3 China Antibody Drugs Price Forecast by Type (2022-2027) 6.5 China Antibody Drugs Historic Market Review by Application (2016-2021) 6.5.1 China Antibody Drugs Sales Market Share by Application (2016-2021) 6.5.2 China Antibody Drugs Revenue Market Share by Application (2016-2021) 6.5.3 China Antibody Drugs Price by Application (2016-2021) 6.6 China Antibody Drugs Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Antibody Drugs Sales Forecast by Application (2022-2027) 6.6.2 China Antibody Drugs Revenue Forecast by Application (2022-2027) 6.6.3 China Antibody Drugs Price Forecast by Application (2022-2027) 7 North America 7.1 North America Antibody Drugs Market Size YoY Growth 2016-2027 7.2 North America Antibody Drugs Market Facts & Figures by Country 7.2.1 North America Antibody Drugs Sales by Country (2016-2021) 7.2.2 North America Antibody Drugs Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Antibody Drugs Market Size YoY Growth 2016-2027 8.2 Asia Pacific Antibody Drugs Market Facts & Figures by Region 8.2.1 Asia Pacific Antibody Drugs Sales by Region (2016-2021) 8.2.2 Asia Pacific Antibody Drugs Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Antibody Drugs Market Size YoY Growth 2016-2027 9.2 Europe Antibody Drugs Market Facts & Figures by Country 9.2.1 Europe Antibody Drugs Sales by Country (2016-2021) 9.2.2 Europe Antibody Drugs Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Antibody Drugs Market Size YoY Growth 2016-2027 10.2 Latin America Antibody Drugs Market Facts & Figures by Country 10.2.1 Latin America Antibody Drugs Sales by Country (2016-2021) 10.2.2 Latin America Antibody Drugs Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Antibody Drugs Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Antibody Drugs Market Facts & Figures by Country 11.2.1 Middle East and Africa Antibody Drugs Sales by Country (2016-2021) 11.2.2 Middle East and Africa Antibody Drugs Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 U.A.E 12 Company Profiles 12.1 Novartis 12.1.1 Novartis Corporation Information 12.1.2 Novartis Description and Business Overview 12.1.3 Novartis Antibody Drugs Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Novartis Antibody Drugs Products Offered 12.1.5 Novartis Recent Development 12.2 Amgen 12.2.1 Amgen Corporation Information 12.2.2 Amgen Description and Business Overview 12.2.3 Amgen Antibody Drugs Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Amgen Antibody Drugs Products Offered 12.2.5 Amgen Recent Development 12.3 Bristol-Myers Squibb 12.3.1 Bristol-Myers Squibb Corporation Information 12.3.2 Bristol-Myers Squibb Description and Business Overview 12.3.3 Bristol-Myers Squibb Antibody Drugs Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Bristol-Myers Squibb Antibody Drugs Products Offered 12.3.5 Bristol-Myers Squibb Recent Development 12.4 F. Hoffmann-La Roche 12.4.1 F. Hoffmann-La Roche Corporation Information 12.4.2 F. Hoffmann-La Roche Description and Business Overview 12.4.3 F. Hoffmann-La Roche Antibody Drugs Sales, Revenue and Gross Margin (2016-2021) 12.4.4 F. Hoffmann-La Roche Antibody Drugs Products Offered 12.4.5 F. Hoffmann-La Roche Recent Development 12.5 Johnson & Johnson 12.5.1 Johnson & Johnson Corporation Information 12.5.2 Johnson & Johnson Description and Business Overview 12.5.3 Johnson & Johnson Antibody Drugs Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Johnson & Johnson Antibody Drugs Products Offered 12.5.5 Johnson & Johnson Recent Development 12.6 AbbVie 12.6.1 AbbVie Corporation Information 12.6.2 AbbVie Description and Business Overview 12.6.3 AbbVie Antibody Drugs Sales, Revenue and Gross Margin (2016-2021) 12.6.4 AbbVie Antibody Drugs Products Offered 12.6.5 AbbVie Recent Development 12.7 Eli Lilly 12.7.1 Eli Lilly Corporation Information 12.7.2 Eli Lilly Description and Business Overview 12.7.3 Eli Lilly Antibody Drugs Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Eli Lilly Antibody Drugs Products Offered 12.7.5 Eli Lilly Recent Development 12.8 Pfizer 12.8.1 Pfizer Corporation Information 12.8.2 Pfizer Description and Business Overview 12.8.3 Pfizer Antibody Drugs Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Pfizer Antibody Drugs Products Offered 12.8.5 Pfizer Recent Development 12.9 Bayer 12.9.1 Bayer Corporation Information 12.9.2 Bayer Description and Business Overview 12.9.3 Bayer Antibody Drugs Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Bayer Antibody Drugs Products Offered 12.9.5 Bayer Recent Development 12.10 GlaxoSmithKline 12.10.1 GlaxoSmithKline Corporation Information 12.10.2 GlaxoSmithKline Description and Business Overview 12.10.3 GlaxoSmithKline Antibody Drugs Sales, Revenue and Gross Margin (2016-2021) 12.10.4 GlaxoSmithKline Antibody Drugs Products Offered 12.10.5 GlaxoSmithKline Recent Development 12.11 Novartis 12.11.1 Novartis Corporation Information 12.11.2 Novartis Description and Business Overview 12.11.3 Novartis Antibody Drugs Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Novartis Antibody Drugs Products Offered 12.11.5 Novartis Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Antibody Drugs Industry Trends 13.2 Antibody Drugs Market Drivers 13.3 Antibody Drugs Market Challenges 13.4 Antibody Drugs Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Antibody Drugs Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Antibody Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Monoclonal Antibodies Table 3. Major Manufacturers of Antibody-Drug Conjugates Table 4. Major Manufacturers of Polyclonal Antibodies Table 5. Global Antibody Drugs Market Size Growth Rate by Application (2021-2027) & (mg) Table 6. Global Antibody Drugs Market Size by Region (mg) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Antibody Drugs Sales by Regions (2016-2021) & (mg) Table 8. Global Antibody Drugs Sales Market Share by Regions (2016-2021) Table 9. Global Antibody Drugs Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Antibody Drugs Sales Forecast by Region (2022-2027) & (mg) Table 11. Global Antibody Drugs Sales Market Share Forecast by Region (2022-2027) Table 12. Global Antibody Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Antibody Drugs Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Antibody Drugs Sales by Manufacturers (2016-2021) (mg) Table 15. Global Antibody Drugs Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Antibody Drugs Manufacturers by Revenue (US$ Million) in 2020 Table 17. Antibody Drugs Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Antibody Drugs Revenue Share by Manufacturers (2016-2021) Table 19. Global Antibody Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Antibody Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Drugs as of 2020) Table 21. Key Manufacturers Antibody Drugs Price (2016-2021) (USD/mg) Table 22. Antibody Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Antibody Drugs Product Type Table 24. Date of International Manufacturers Enter into Antibody Drugs Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Antibody Drugs Sales by Type (2016-2021) (mg) Table 27. Global Antibody Drugs Sales Share by Type (2016-2021) Table 28. Global Antibody Drugs Revenue by Type (2016-2021) (US$ Million) Table 29. Global Antibody Drugs Revenue Share by Type (2016-2021) Table 30. Antibody Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/mg) Table 31. Global Antibody Drugs Sales Forecast by Type (2022-2027) & (mg) Table 32. Global Antibody Drugs Sales Market Share Forecast by Type (2022-2027) Table 33. Global Antibody Drugs Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Antibody Drugs Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Antibody Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/mg) Table 36. Global Antibody Drugs Sales by Application (2016-2021) (mg) Table 37. Global Antibody Drugs Sales Share by Application (2016-2021) Table 38. Global Antibody Drugs Revenue by Application (2016-2021) (US$ Million) Table 39. Global Antibody Drugs Revenue Share by Application (2016-2021) Table 40. Antibody Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/mg) Table 41. Global Antibody Drugs Sales Forecast by Application (2022-2027) & (mg) Table 42. Global Antibody Drugs Sales Market Share Forecast by Application (2022-2027) Table 43. Global Antibody Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Antibody Drugs Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Antibody Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/mg) Table 46. China Antibody Drugs Sales (mg) of Key Companies (2016-2021) Table 47. China Antibody Drugs Sales Share by Company (2016-2021) Table 48. China Antibody Drugs Revenue (US$ Million) by Company (2016-2021) Table 49. China Antibody Drugs Revenue Share by Company (2016-2021) Table 50. China Antibody Drugs Sales (mg) by Type (2016-2021) Table 51. China Antibody Drugs Sales Share by Type (2016-2021) Table 52. China Antibody Drugs Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. China Antibody Drugs Price (USD/mg) by Type (2016-2021) Table 54. China Antibody Drugs Sales (mg) by Type (2022-2027) Table 55. China Antibody Drugs Sales Share by Type (2022-2027) Table 56. China Antibody Drugs Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. China Antibody Drugs Revenue Share by Type (2022-2027) Table 58. China Antibody Drugs Price (USD/mg) by Type (2022-2027) Table 59. China Antibody Drugs Sales (mg) by Application (2016-2021) Table 60. China Antibody Drugs Sales Share by Application (2016-2021) Table 61. China Antibody Drugs Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. China Antibody Drugs Price (USD/mg) by Application (2016-2021) Table 63. China Antibody Drugs Sales (mg) by Application (2022-2027) Table 64. China Antibody Drugs Sales Share by Application (2022-2027) Table 65. China Antibody Drugs Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. China Antibody Drugs Revenue Share by Application (2022-2027) Table 67. China Antibody Drugs Price (USD/mg) by Application (2022-2027) Table 68. North America Antibody Drugs Sales by Country (2016-2021) & (mg) Table 69. North America Antibody Drugs Sales Market Share by Country (2016-2021) Table 70. North America Antibody Drugs Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Antibody Drugs Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Antibody Drugs Sales by Region (2016-2021) & (mg) Table 73. Asia Pacific Antibody Drugs Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Antibody Drugs Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Antibody Drugs Revenue Market Share by Region (2016-2021) Table 76. Europe Antibody Drugs Sales by Country (2016-2021) & (mg) Table 77. Europe Antibody Drugs Sales Market Share by Country (2016-2021) Table 78. Europe Antibody Drugs Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Antibody Drugs Revenue Market Share by Country (2016-2021) Table 80. Latin America Antibody Drugs Sales by Country (2016-2021) & (mg) Table 81. Latin America Antibody Drugs Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Antibody Drugs Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Antibody Drugs Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Antibody Drugs Sales by Country (2016-2021) & (mg) Table 85. Middle East and Africa Antibody Drugs Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Antibody Drugs Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Antibody Drugs Revenue Market Share by Country (2016-2021) Table 88. Novartis Corporation Information Table 89. Novartis Description and Business Overview Table 90. Novartis Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2016-2021) Table 91. Novartis Antibody Drugs Product Table 92. Novartis Recent Development Table 93. Amgen Corporation Information Table 94. Amgen Description and Business Overview Table 95. Amgen Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2016-2021) Table 96. Amgen Product Table 97. Amgen Recent Development Table 98. Bristol-Myers Squibb Corporation Information Table 99. Bristol-Myers Squibb Description and Business Overview Table 100. Bristol-Myers Squibb Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2016-2021) Table 101. Bristol-Myers Squibb Product Table 102. Bristol-Myers Squibb Recent Development Table 103. F. Hoffmann-La Roche Corporation Information Table 104. F. Hoffmann-La Roche Description and Business Overview Table 105. F. Hoffmann-La Roche Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2016-2021) Table 106. F. Hoffmann-La Roche Product Table 107. F. Hoffmann-La Roche Recent Development Table 108. Johnson & Johnson Corporation Information Table 109. Johnson & Johnson Description and Business Overview Table 110. Johnson & Johnson Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2016-2021) Table 111. Johnson & Johnson Product Table 112. Johnson & Johnson Recent Development Table 113. AbbVie Corporation Information Table 114. AbbVie Description and Business Overview Table 115. AbbVie Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2016-2021) Table 116. AbbVie Product Table 117. AbbVie Recent Development Table 118. Eli Lilly Corporation Information Table 119. Eli Lilly Description and Business Overview Table 120. Eli Lilly Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2016-2021) Table 121. Eli Lilly Product Table 122. Eli Lilly Recent Development Table 123. Pfizer Corporation Information Table 124. Pfizer Description and Business Overview Table 125. Pfizer Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2016-2021) Table 126. Pfizer Product Table 127. Pfizer Recent Development Table 128. Bayer Corporation Information Table 129. Bayer Description and Business Overview Table 130. Bayer Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2016-2021) Table 131. Bayer Product Table 132. Bayer Recent Development Table 133. GlaxoSmithKline Corporation Information Table 134. GlaxoSmithKline Description and Business Overview Table 135. GlaxoSmithKline Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2016-2021) Table 136. GlaxoSmithKline Product Table 137. GlaxoSmithKline Recent Development Table 138. Sanofi Corporation Information Table 139. Sanofi Description and Business Overview Table 140. Sanofi Antibody Drugs Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2016-2021) Table 141. Sanofi Product Table 142. Sanofi Recent Development Table 143. Antibody Drugs Market Trends Table 144. Antibody Drugs Market Drivers Table 145. Antibody Drugs Market Challenges Table 146. Antibody Drugs Market Restraints Table 147. Antibody Drugs Customers List Table 148. Antibody Drugs Distributors List Table 149. Research Programs/Design for This Report Table 150. Key Data Information from Secondary Sources Table 151. Key Data Information from Primary Sources List of Figures Figure 1. Antibody Drugs Product Picture Figure 2. Global Antibody Drugs Sales Market Share by Type in 2020 & 2027 Figure 3. Monoclonal Antibodies Product Picture Figure 4. Antibody-Drug Conjugates Product Picture Figure 5. Polyclonal Antibodies Product Picture Figure 6. Global Antibody Drugs Sales Market Share by Application in 2020 & 2027 Figure 7. Central Nervous System (CNS) Disorders Figure 8. Cancers Figure 9. Autoimmune Disorders Figure 10. Cardiovascular Diseases Figure 11. Antibody Drugs Report Years Considered Figure 12. Global Antibody Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Antibody Drugs Market Size 2016-2027 (US$ Million) Figure 14. Global Antibody Drugs Sales 2016-2027 (mg) Figure 15. Global Antibody Drugs Market Size Market Share by Region: 2021 Versus 2027 Figure 16. Global Antibody Drugs Sales Market Share by Region (2016-2021) Figure 17. Global Antibody Drugs Sales Market Share by Region in 2020 Figure 18. Global Antibody Drugs Revenue Market Share by Region (2016-2021) Figure 19. Global Antibody Drugs Revenue Market Share by Region in 2020 Figure 20. Global Antibody Drugs Sales Share by Manufacturer in 2020 Figure 21. The Top 10 and 5 Players Market Share by Antibody Drugs Revenue in 2020 Figure 22. Antibody Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Antibody Drugs Sales Market Share by Type (2016-2021) Figure 24. Global Antibody Drugs Sales Market Share by Type in 2020 Figure 25. Global Antibody Drugs Revenue Market Share by Type (2016-2021) Figure 26. Global Antibody Drugs Revenue Market Share by Type in 2020 Figure 27. Global Antibody Drugs Sales Market Share by Application (2016-2021) Figure 28. Global Antibody Drugs Sales Market Share by Application in 2020 Figure 29. Global Antibody Drugs Revenue Market Share by Application (2016-2021) Figure 30. Global Antibody Drugs Revenue Market Share by Application in 2020 Figure 31. China Antibody Drugs Sales Growth Rate 2016-2027 (mg) Figure 32. China Antibody Drugs Revenue Growth Rate 2016-2027 (US$ Million) Figure 33. China Antibody Drugs Market Share in Global Market 2016-2027 Figure 34. China 5 and 10 Largest Antibody Drugs Players Market Share by Revenue in Antibody Drugs in 2020 Figure 35. China Antibody Drugs Revenue Share by Type (2016-2021) Figure 36. China Antibody Drugs Revenue Growth Rate by Type in 2016 & 2020 Figure 37. China Antibody Drugs Revenue Share by Application (2016-2021) Figure 38. China Antibody Drugs Revenue Growth Rate by Application in 2016 & 2020 Figure 39. North America Antibody Drugs Sales Growth Rate 2016-2021 (mg) Figure 40. North America Antibody Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 41. North America Antibody Drugs Sales Market Share by Country in 2020 Figure 42. North America Antibody Drugs Revenue Market Share by Country in 2020 Figure 43. U.S. Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 44. U.S. Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Canada Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 46. Canada Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Europe Antibody Drugs Sales Growth Rate 2016-2021 (mg) Figure 48. Europe Antibody Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 49. Europe Antibody Drugs Sales Market Share by Country in 2020 Figure 50. Europe Antibody Drugs Revenue Market Share by Country in 2020 Figure 51. Germany Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 52. Germany Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 53. France Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 54. France Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 55. U.K. Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 56. U.K. Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 57. Italy Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 58. Italy Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 59. Russia Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 60. Russia Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 61. Asia Pacific Antibody Drugs Sales Growth Rate 2016-2021 (mg) Figure 62. Asia Pacific Antibody Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 63. Asia Pacific Antibody Drugs Sales Market Share by Region in 2020 Figure 64. Asia Pacific Antibody Drugs Revenue Market Share by Region in 2020 Figure 65. China Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 66. China Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 67. Japan Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 68. Japan Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 69. South Korea Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 70. South Korea Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 71. India Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 72. India Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 73. Australia Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 74. Australia Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 75. Taiwan Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 76. Taiwan Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 77. Indonesia Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 78. Indonesia Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 79. Thailand Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 80. Thailand Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 81. Malaysia Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 82. Malaysia Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 83. Philippines Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 84. Philippines Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 85. Vietnam Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 86. Vietnam Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 87. Latin America Antibody Drugs Sales Growth Rate 2016-2021 (mg) Figure 88. Latin America Antibody Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 89. Latin America Antibody Drugs Sales Market Share by Country in 2020 Figure 90. Latin America Antibody Drugs Revenue Market Share by Country in 2020 Figure 91. Mexico Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 92. Mexico Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 93. Brazil Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 94. Brazil Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 95. Argentina Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 96. Argentina Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 97. Middle East and Africa Antibody Drugs Sales Growth Rate 2016-2021 (mg) Figure 98. Middle East and Africa Antibody Drugs Revenue Growth Rate 2016-2021 (US$ Million) Figure 99. Middle East and Africa Antibody Drugs Sales Market Share by Country in 2020 Figure 100. Middle East and Africa Antibody Drugs Revenue Market Share by Country in 2020 Figure 101. Turkey Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 102. Turkey Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 103. Saudi Arabia Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 104. Saudi Arabia Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 105. U.A.E Antibody Drugs Sales Growth Rate (2016-2021) (mg) Figure 106. U.A.E Antibody Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 107. Antibody Drugs Value Chain Figure 108. Channels of Distribution Figure 109. Distributors Profiles Figure 110. Bottom-up and Top-down Approaches for This Report Figure 111. Data Triangulation Figure 112. Key Executives Interviewed

Novartis Amgen Bristol-Myers Squibb F. Hoffmann-La Roche Johnson & Johnson AbbVie Eli Lilly Pfizer Bayer GlaxoSmithKline Sanofi